Newsfeeds - Spark Newswire

3 minute read

Jim Cramer Says China’s Vaccines ‘Don’t Work’ But Xi Won’t Admit It

Today, 6:36 PM

COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.

BNTX

1 minute read

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile

By Bill Haddad

Today, 6:36 PM

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de Salud

SVA

5 minute read

Uncategorized

CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

By The Bamboo Works

Today, 6:36 PM

Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited benefits for the company as the pandemic fades and other products are widely available By Jony Ho

BNTX

5 minute read

New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report

By The Bamboo Works

Today, 6:36 PM

Investors kept a close look at China’s solar and wind power stocks last year, but were least interested in the hobbled education sector By Bamboo Works team

API

1 minute read

Sinovac’s COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters

By Vandana Singh

Today, 6:36 PM

China-based Sinovac Biotech Ltd's (NASDAQ: SVA) two-dose COVID-19 vaccine followed by a booster Pfizer Inc (NYSE: PFE) -BioNTech SE (NASDAQ:

BNTX

1 minute read

News

Three Sinovac Doses Fail to Protect Against Omicron in Study

By Charles Gross

Today, 6:36 PM

-Bloomberg https://www.bloomberg.com/news/articles/2021-12-23/three-sinovac-doses-fail-to-protect-against-omicron-study-shows?utm_source=google&utm_medium=bd&cmpId=google&sref=V7uxlNge

SVA

1 minute read

Legal
News

Sinovac Says Beijing Settled Litigation Of Its Business License And Seals BZ NOTE: Shares Of Sinovac Have Not Traded In Over A Year

By Benzinga Newsdesk

Today, 6:36 PM

SINOVAC Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced the Company's subsidiary SINOVAC Biotech Co., Ltd

SVA

1 minute read

Sinovac’s COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters

By Vandana Singh

Today, 6:36 PM

According to a real-world study from Malaysia, Sinovac Biotech Ltd's (NASDAQ: SVA) COVID-19 vaccine, CoronaVac, showed effectiveness against serious illness.

AZN

6 minute read

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization

By Shanthi Rexaline

Today, 6:36 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)

ABSI

1 minute read

New Research On SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including The Delta Variant

By Benzinga Newsdesk

Today, 6:36 PM

SINOVAC Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced a paper, titled “A third dose of inactivated vaccine

SVA